Caribou Biosciences (CRBU) Net Margin (QoQ) (2020 - 2026)
Caribou Biosciences (CRBU) Net Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Caribou Biosciences | 156.25 Mn | 38.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43,913.00 |
| Dec 31, 2025 | 74,043.00 |
| Sep 30, 2025 | 31,609.00 |
| Jun 30, 2025 | 3,875.00 |
| Mar 31, 2025 | 11,182.00 |
| Dec 31, 2024 | 181,900.00 |
| Sep 30, 2024 | -212,612.00 |
| Jun 30, 2024 | 196,303.00 |
| Mar 31, 2024 | -254,072.00 |
| Dec 31, 2023 | -92,956.00 |
| Sep 30, 2023 | 191,542.00 |
| Jun 30, 2023 | -114,445.00 |
| Mar 31, 2023 | -5,555.00 |
| Dec 31, 2022 | 71,514.00 |
| Sep 30, 2022 | 25,846.00 |
| Jun 30, 2022 | -96,401.00 |
| Mar 31, 2022 | -12,916.00 |
| Dec 31, 2021 | -19,474.00 |
| Sep 30, 2021 | 44,220.00 |
| Jun 30, 2021 | -13,988.00 |